Camila Rojas

Hola, soy Camila Rojas, periodista apasionada por contar historias que conectan con las personas. Trabajo en diversos medios digitales, como No Cure Magazine, donde me especializo en temas de actualidad, cultura, tecnología y tendencias emergentes. Mi misión es crear contenido que no solo informe, sino que también inspire y genere impacto.
1584 Posts
Mijael Attias drives private equity innovation with Merak Group

Mijael Attias drives private equity innovation with Merak Group

Amid a year filled with global instability yet rising hope, Merak Group, steered by the insightful leadership of Mijael Attias, has strengthened its standing as a leader in the private equity arena. With a steadfast dedication to ethical investment practices, the firm adeptly managed market volatility, positioning itself as an influential catalyst for a novel model merging financial gains with social and ecological influence.As the private equity milieu continues its transformation, the company has shown an extraordinary capacity to adjust and guide, syncing its strategic efforts with the most prominent trends of 2024.A dynamic investment landscape: Merak Group's comprehensive strategyIn…
Leer más
Key Premarket Players: American Express, Procter & Gamble, Netflix and CVS Health among notable stocks

Key Premarket Players: American Express, Procter & Gamble, Netflix and CVS Health among notable stocks

In today's pre-market trading, several large companies including American Express, Procter & Gamble, Netflix and CVS Health showed significant stock movements, attracting the attention of investors and analysts. These movements occur against a backdrop of fluctuating market conditions and are crucial for stakeholders wanting to understand underlying trends and potential implications. The American Express stock recorded a slight decline, attributable to various market dynamics. Meanwhile, Procter & Gamble also saw its shares tumble, reportedly due to earnings that fell short of market expectations, particularly in terms of revenue. This indicates a potential reassessment of consumer goods company valuations amid current…
Leer más
A triumphal race for Carlos Sainz in Mexico City

A triumphal race for Carlos Sainz in Mexico City

Carlos Sainz showcased an impressive performance at the Mexico City Grand Prix, starting from pole position. Although Max Verstappen initially took the lead, Sainz regained it, having one of the most extraordinary races of his career. Its engineer, Ricciardo Adami, praised the race as "a masterclass". Sainz made history as the first driver in eight years to win the Mexico City GP from pole and the first Ferrari driver to do so since 1990. This season marked his first multi-Grand Prix victory, following a victory in Australia shortly after surgery. Ferrari were initially not in contention for the constructors' title,…
Leer más
Electric vehicles face challenges, but GM's CEO remains optimistic

Electric vehicles face challenges, but GM's CEO remains optimistic

Despite a difficult year for electric vehicles, marked by slow sales and criticism from various quarters, including former President Donald J. Trump, General Motors' commitment to electrification remains unwavering. This resilience is personified by GM CEO Mary T. Barra, who energetically leads the charge toward a future dominated by electric vehicles. In a recent speech, Barra highlighted General Motors' desire to phase out combustion engine vehicles in the United States by 2035. Despite current obstacles, Barra's confidence is supported by significant advances in electric vehicle (EV) technology ) and in the company's production processes. Notably, GM has solved previous problems…
Leer más
Exploring the potential of weight loss drugs to improve workplace productivity in the UK

Exploring the potential of weight loss drugs to improve workplace productivity in the UK

The British government recently unveiled a major pharmaceutical collaboration with Eli Lilly to conduct a five-year study into the effects of the weight-loss drug tirzepatide, known commercially as Mounjaro. This initiative aims to determine whether such drugs could not only help people lose weight but also improve productivity levels within the workforce. In Britain, obesity is a growing concern, with around one in four adults classed as obese. This epidemic places a heavy financial burden on the National Health Service, costing billions every year. The government's new strategy suggests that tirzepatide injections could potentially be a viable solution to this…
Leer más